Antibiotic resistance is a bacterial defense mechanism against antibiotics. It can rapidly spread from one bacterium to another. This makes antibiotics increasingly ineffective.
Detailed description
The level of resistances against antibiotics is rising. This is a great challenge for physicians and scientists. Scientists within the DZIF research field “Healthcare-associated and Antibiotic-resistant bacterial Infections” aim to develop new strategies against the development and spread of resistance.
A potential lifesaver lies unrecognized in the human body: Scientists at the University of Tübingen and the German Center for Infection Research (DZIF) have discovered that Staphylococcus lugdunensis
Hopes for tuberculosis treatment have been raised by an international study in which DZIF scientists from the Research Center Borstel were also involved. Resistance to pyrazinamide und
An international team of scientists has had unexpected success in treating tuberculosis with a ß-lactam antibiotic that is approved for other indications. DZIF scientists from the Research Center
The mcr-1 gene makes gut bacteria insensitive to the last-resort antibioticcolistin. Especially in hospitals, colistin is used as a last treatment option for infections with dreaded multidrug
Salmonella infections in the bloodstream, caused by Salmonella enterica bacteria, are still the cause of many deaths in southern regions and Southeast Asia. Children between the age of two and five
DZIF scientists at the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) have succeeded in identifying and targeting problematic pathogens in biofilms more rapidly. The biofilm adhesion
World Tuberculosis Day on 24 March is a reminder to the public that 1.5 people still die of tuberculosis (TB) every year. The rise of multidrug-resistant strains is particularly problematic, currently
Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the
Researchers from the German Center for Infection Research (DZIF) and the University of Giessen have shown that the gene for resistance to colistin, which was recently discovered in China, also exists
His aim is to develop a vaccine against the widespread gastric pathogenHelicobacter pylori: for his work in this field, Professor Markus Gerhard, Technische Universität München (TUM), was awarded the
